Since most cancers, including melanoma, evade immune detection by downregulating MHC-I, by inducing a higher MHC-I expression, we could potentially improve the tumor recognition by infiltrating CD8+ T cells through the MHC-I/TCR interaction [44]. This evidence concerns the gene CD8A and neoplasm.